NEWS IN BRIEF
Aurobindo recalls depression treatment over mislabeled strength
Aurobindo announces a voluntary recall of mirtazapine tablets after bottles of tablets marked as 7.5mg were found to potentially contain 15mg tablets.
NEWS IN BRIEF
Aurobindo announces a voluntary recall of mirtazapine tablets after bottles of tablets marked as 7.5mg were found to potentially contain 15mg tablets.
ClinOne looks to further support its clinical trial partners in the European Union by opening its first office in the region, located in London, UK.
Mylan and Micro Labs receive US FDA approval for two generic versions of Pfizer and BMS’ Eliquis, marking the first generic approvals of direct oral anticoagulants.
Cyclo Therapeutics signs master services agreement with Worldwide Clinical Trials for studies in two indications.
Sponsors should ‘continually’ think about providing tools to help healthcare professionals discuss clinical trials with women and older people.
GSK and Pfizer joint venture suffers regulatory rejection after US FDA finds fault with filing.